nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—S100A12—nose—cleft lip	0.0936	0.32	CbGeAlD
Amlexanox—FGF1—periosteum—cleft lip	0.0387	0.132	CbGeAlD
Amlexanox—FGF1—cartilage tissue—cleft lip	0.0271	0.0926	CbGeAlD
Amlexanox—IL3—embryo—cleft lip	0.0268	0.0917	CbGeAlD
Amlexanox—PDE4C—tongue—cleft lip	0.0199	0.0679	CbGeAlD
Amlexanox—PDE4C—mouth—cleft lip	0.0134	0.0456	CbGeAlD
Amlexanox—FGF1—mouth—cleft lip	0.011	0.0376	CbGeAlD
Amlexanox—FGF1—embryo—cleft lip	0.00784	0.0268	CbGeAlD
Amlexanox—PDE4C—telencephalon—cleft lip	0.00774	0.0265	CbGeAlD
Amlexanox—PDE4D—telencephalon—cleft lip	0.00682	0.0233	CbGeAlD
Amlexanox—S100A13—head—cleft lip	0.00645	0.022	CbGeAlD
Amlexanox—FGF1—telencephalon—cleft lip	0.00638	0.0218	CbGeAlD
Amlexanox—S100A12—head—cleft lip	0.00636	0.0217	CbGeAlD
Amlexanox—PDE4A—telencephalon—cleft lip	0.00603	0.0206	CbGeAlD
Amlexanox—PDE4C—head—cleft lip	0.00482	0.0165	CbGeAlD
Amlexanox—FGF1—head—cleft lip	0.00397	0.0136	CbGeAlD
Amlexanox—PDE4B—telencephalon—cleft lip	0.0036	0.0123	CbGeAlD
Amlexanox—PDE4B—head—cleft lip	0.00224	0.00765	CbGeAlD
Amlexanox—FGF1—Signaling Pathways—ARHGAP29—cleft lip	0.000482	0.000682	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—WNT9B—cleft lip	0.00048	0.000678	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—FGFR3—cleft lip	0.000475	0.000672	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—FGFR3—cleft lip	0.000475	0.000672	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—FGF9—cleft lip	0.000473	0.000669	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—FGFR1—cleft lip	0.000473	0.000668	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—FGF9—cleft lip	0.000472	0.000668	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—FGFR1—cleft lip	0.00047	0.000665	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—FGFR2—cleft lip	0.00047	0.000665	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—FGFR2—cleft lip	0.00047	0.000665	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—FGFR2—cleft lip	0.00047	0.000665	CbGpPWpGaD
Amlexanox—IL3—Immune System—FGF7—cleft lip	0.000469	0.000663	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—FGFR1—cleft lip	0.000468	0.000662	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—FGFR3—cleft lip	0.000468	0.000661	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—FGFR2—cleft lip	0.000466	0.000659	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—FGFR1—cleft lip	0.000466	0.000659	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—FGFR2—cleft lip	0.000462	0.000653	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—FGFR2—cleft lip	0.00046	0.00065	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—FGFR1—cleft lip	0.000459	0.000649	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—WNT3—cleft lip	0.000458	0.000648	CbGpPWpGaD
Amlexanox—FGF1—Signaling by Insulin receptor—FGF2—cleft lip	0.000449	0.000635	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—FGFR3—cleft lip	0.000447	0.000632	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—FGFR3—cleft lip	0.000445	0.000629	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—FGFR3—cleft lip	0.000442	0.000626	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—FGFR3—cleft lip	0.00044	0.000622	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—FGFR1—cleft lip	0.000438	0.00062	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—FGFR1—cleft lip	0.000438	0.00062	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—FGFR1—cleft lip	0.000438	0.00062	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—FGFR2—cleft lip	0.000435	0.000615	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—FGFR1—cleft lip	0.000434	0.000614	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—cleft lip	0.000434	0.000614	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—WNT3—cleft lip	0.000433	0.000612	CbGpPWpGaD
Amlexanox—IL3—Immune System—FGF8—cleft lip	0.000432	0.000611	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—FGFR1—cleft lip	0.000431	0.000609	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.00043	0.000608	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—FGFR1—cleft lip	0.000429	0.000606	CbGpPWpGaD
Amlexanox—PDE4D—Myometrial Relaxation and Contraction Pathways—NOS3—cleft lip	0.000428	0.000604	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—PTCH1—cleft lip	0.000425	0.000601	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—FGFR2—cleft lip	0.000416	0.000589	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—FGFR3—cleft lip	0.000414	0.000586	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—FGFR3—cleft lip	0.000414	0.000586	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—FGFR3—cleft lip	0.000414	0.000586	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000412	0.000583	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—WNT3—cleft lip	0.000412	0.000582	CbGpPWpGaD
Amlexanox—S100A12—Immune System—SUMO1—cleft lip	0.000411	0.000581	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—FGFR3—cleft lip	0.000411	0.00058	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—FGFR3—cleft lip	0.000407	0.000575	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—FGFR1—cleft lip	0.000406	0.000573	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—FGFR3—cleft lip	0.000405	0.000573	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—FGF10—cleft lip	0.000399	0.000564	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—FGF10—cleft lip	0.000398	0.000563	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—FGFR1—cleft lip	0.000388	0.000549	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—FGF2—cleft lip	0.000384	0.000543	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—FGFR3—cleft lip	0.000383	0.000542	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—WNT3—cleft lip	0.000381	0.000539	CbGpPWpGaD
Amlexanox—FGF1—Disease—WNT9B—cleft lip	0.000377	0.000533	CbGpPWpGaD
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—NOS3—cleft lip	0.000377	0.000532	CbGpPWpGaD
Amlexanox—S100A12—Immune System—FGF7—cleft lip	0.000376	0.000531	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—WNT9B—cleft lip	0.00037	0.000522	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—FGF7—cleft lip	0.000369	0.000521	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—FGF2—cleft lip	0.000367	0.000519	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—FGF2—cleft lip	0.000367	0.000519	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	0.000367	0.000519	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—FGF2—cleft lip	0.000362	0.000511	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOG—cleft lip	0.000354	0.000501	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FGF7—cleft lip	0.000354	0.0005	CbGpPWpGaD
Amlexanox—IL3—Immune System—FGF3—cleft lip	0.000352	0.000498	CbGpPWpGaD
Amlexanox—S100A12—Immune System—FGF8—cleft lip	0.000347	0.00049	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—FGF2—cleft lip	0.000345	0.000488	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—FGF2—cleft lip	0.000344	0.000486	CbGpPWpGaD
Amlexanox—IL3—Immune System—FGF9—cleft lip	0.000343	0.000485	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IRF6—cleft lip	0.000342	0.000484	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—FGF2—cleft lip	0.000342	0.000483	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—FGF2—cleft lip	0.00034	0.000481	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—FGF8—cleft lip	0.00034	0.000481	CbGpPWpGaD
Amlexanox—FGF1—Disease—ABCA4—cleft lip	0.000336	0.000475	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—FGF2—cleft lip	0.000335	0.000474	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ABCA4—cleft lip	0.000329	0.000466	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FGF8—cleft lip	0.000327	0.000462	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—WNT9B—cleft lip	0.000322	0.000455	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—FGFR2—cleft lip	0.00032	0.000453	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—FGF2—cleft lip	0.00032	0.000453	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—FGF2—cleft lip	0.00032	0.000453	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—FGF2—cleft lip	0.00032	0.000453	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—FGFR2—cleft lip	0.00032	0.000452	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—FGF2—cleft lip	0.000317	0.000449	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—FGF2—cleft lip	0.000314	0.000445	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—FGF2—cleft lip	0.000313	0.000443	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOG—cleft lip	0.000308	0.000436	CbGpPWpGaD
Amlexanox—FGF1—Disease—SLC19A1—cleft lip	0.000308	0.000435	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—WNT9B—cleft lip	0.000306	0.000433	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FGF7—cleft lip	0.000303	0.000428	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SPRY2—cleft lip	0.000303	0.000428	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000301	0.000426	CbGpPWpGaD
Amlexanox—FGF1—Disease—WNT3—cleft lip	0.0003	0.000424	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—FGFR1—cleft lip	0.000299	0.000422	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—FGFR1—cleft lip	0.000298	0.000421	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—NOS3—cleft lip	0.000297	0.000421	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—FGF2—cleft lip	0.000296	0.000419	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—WNT3—cleft lip	0.000294	0.000415	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOG—cleft lip	0.000294	0.000415	CbGpPWpGaD
Amlexanox—IL3—Immune System—FGF10—cleft lip	0.00029	0.000409	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ABCA4—cleft lip	0.000287	0.000405	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.000284	0.000401	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—WNT9B—cleft lip	0.000283	0.000401	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—FGFR3—cleft lip	0.000282	0.000399	CbGpPWpGaD
Amlexanox—S100A12—Immune System—FGF3—cleft lip	0.000282	0.000399	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—FGFR3—cleft lip	0.000282	0.000398	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FGF8—cleft lip	0.00028	0.000395	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—FGF3—cleft lip	0.000277	0.000391	CbGpPWpGaD
Amlexanox—S100A12—Immune System—FGF9—cleft lip	0.000275	0.000389	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ABCA4—cleft lip	0.000273	0.000386	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—PTCH1—cleft lip	0.000272	0.000385	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOG—cleft lip	0.000272	0.000384	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—FGF9—cleft lip	0.00027	0.000382	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FGF3—cleft lip	0.000266	0.000376	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—WNT9B—cleft lip	0.000264	0.000373	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FGF9—cleft lip	0.000259	0.000366	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—WNT3—cleft lip	0.000256	0.000361	CbGpPWpGaD
Amlexanox—FGF1—Disease—TCN2—cleft lip	0.000255	0.00036	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOG—cleft lip	0.000253	0.000358	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ABCA4—cleft lip	0.000253	0.000357	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PTCH1—cleft lip	0.000251	0.000355	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—WNT3—cleft lip	0.000243	0.000344	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—PTCH1—cleft lip	0.000237	0.000335	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ABCA4—cleft lip	0.000235	0.000333	CbGpPWpGaD
Amlexanox—FGF1—Immune System—SUMO1—cleft lip	0.000235	0.000332	CbGpPWpGaD
Amlexanox—IL3—Immune System—FGFR2—cleft lip	0.000232	0.000328	CbGpPWpGaD
Amlexanox—S100A12—Immune System—FGF10—cleft lip	0.000232	0.000328	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—FGF10—cleft lip	0.000228	0.000322	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FGF3—cleft lip	0.000228	0.000322	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—PTCH1—cleft lip	0.000226	0.000319	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—WNT3—cleft lip	0.000225	0.000318	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FGF9—cleft lip	0.000222	0.000314	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FGF10—cleft lip	0.000219	0.000309	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—FGF2—cleft lip	0.000218	0.000308	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—FGF2—cleft lip	0.000218	0.000308	CbGpPWpGaD
Amlexanox—IL3—Immune System—FGFR1—cleft lip	0.000217	0.000306	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGF7—cleft lip	0.000215	0.000303	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—WNT3—cleft lip	0.00021	0.000297	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PTCH1—cleft lip	0.000209	0.000295	CbGpPWpGaD
Amlexanox—IL3—Immune System—FGFR3—cleft lip	0.000205	0.000289	CbGpPWpGaD
Amlexanox—FGF1—Disease—SPRY2—cleft lip	0.000198	0.00028	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGF7—cleft lip	0.000198	0.00028	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGF8—cleft lip	0.000198	0.00028	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000197	0.000278	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGF7—cleft lip	0.000194	0.000274	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SPRY2—cleft lip	0.000194	0.000274	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FGF10—cleft lip	0.000187	0.000265	CbGpPWpGaD
Amlexanox—S100A12—Immune System—FGFR2—cleft lip	0.000186	0.000263	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGF8—cleft lip	0.000183	0.000259	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—FGFR2—cleft lip	0.000183	0.000258	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGF8—cleft lip	0.000179	0.000253	CbGpPWpGaD
Amlexanox—FGF1—Disease—MTR—cleft lip	0.000177	0.00025	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FGFR2—cleft lip	0.000175	0.000248	CbGpPWpGaD
Amlexanox—S100A12—Immune System—FGFR1—cleft lip	0.000174	0.000245	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—FGFR1—cleft lip	0.00017	0.000241	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGF7—cleft lip	0.000169	0.000239	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SPRY2—cleft lip	0.000169	0.000239	CbGpPWpGaD
Amlexanox—S100A12—Immune System—FGFR3—cleft lip	0.000164	0.000232	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FGFR1—cleft lip	0.000164	0.000231	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGF3—cleft lip	0.000161	0.000228	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—FGFR3—cleft lip	0.000161	0.000228	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGF7—cleft lip	0.000161	0.000227	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTCH1—cleft lip	0.000161	0.000227	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SPRY2—cleft lip	0.000161	0.000227	CbGpPWpGaD
Amlexanox—IL3—Immune System—FGF2—cleft lip	0.000158	0.000224	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGF9—cleft lip	0.000157	0.000222	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGF8—cleft lip	0.000156	0.00022	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FGFR3—cleft lip	0.000155	0.000218	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FGFR2—cleft lip	0.00015	0.000212	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGF3—cleft lip	0.000149	0.00021	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGF7—cleft lip	0.000149	0.00021	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SPRY2—cleft lip	0.000149	0.00021	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGF8—cleft lip	0.000148	0.00021	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGF3—cleft lip	0.000146	0.000206	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGF9—cleft lip	0.000145	0.000205	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGF9—cleft lip	0.000142	0.000201	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTCH1—cleft lip	0.00014	0.000198	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FGFR1—cleft lip	0.00014	0.000198	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SPRY2—cleft lip	0.000139	0.000196	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGF7—cleft lip	0.000139	0.000196	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGF8—cleft lip	0.000137	0.000194	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTCH1—cleft lip	0.000133	0.000188	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGF10—cleft lip	0.000133	0.000187	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FGFR3—cleft lip	0.000132	0.000187	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGF8—cleft lip	0.000128	0.000181	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGF3—cleft lip	0.000127	0.000179	CbGpPWpGaD
Amlexanox—S100A12—Immune System—FGF2—cleft lip	0.000127	0.000179	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—FGF2—cleft lip	0.000124	0.000176	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGF9—cleft lip	0.000124	0.000175	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTCH1—cleft lip	0.000123	0.000174	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGF10—cleft lip	0.000122	0.000173	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGF3—cleft lip	0.000121	0.000171	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGF10—cleft lip	0.00012	0.00017	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—FGF2—cleft lip	0.000119	0.000169	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGF9—cleft lip	0.000118	0.000167	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTCH1—cleft lip	0.000115	0.000163	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGF3—cleft lip	0.000112	0.000158	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGF9—cleft lip	0.000109	0.000154	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGFR2—cleft lip	0.000106	0.00015	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGF10—cleft lip	0.000104	0.000148	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGF3—cleft lip	0.000104	0.000147	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FGF2—cleft lip	0.000102	0.000145	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGF9—cleft lip	0.000102	0.000144	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NOS3—cleft lip	0.000101	0.000143	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGF10—cleft lip	9.94e-05	0.00014	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGFR1—cleft lip	9.92e-05	0.00014	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGFR2—cleft lip	9.82e-05	0.000139	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGFR2—cleft lip	9.62e-05	0.000136	CbGpPWpGaD
Amlexanox—FGF1—Disease—MTHFR—cleft lip	9.46e-05	0.000134	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGFR3—cleft lip	9.37e-05	0.000133	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGF10—cleft lip	9.19e-05	0.00013	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGFR1—cleft lip	9.16e-05	0.000129	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGFR1—cleft lip	8.97e-05	0.000127	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGFR3—cleft lip	8.65e-05	0.000122	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGF10—cleft lip	8.57e-05	0.000121	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGFR3—cleft lip	8.48e-05	0.00012	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGFR2—cleft lip	8.38e-05	0.000118	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGFR2—cleft lip	7.97e-05	0.000113	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGFR1—cleft lip	7.81e-05	0.00011	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGFR1—cleft lip	7.43e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGFR3—cleft lip	7.38e-05	0.000104	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGFR2—cleft lip	7.38e-05	0.000104	CbGpPWpGaD
Amlexanox—FGF1—Immune System—FGF2—cleft lip	7.24e-05	0.000102	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGFR3—cleft lip	7.02e-05	9.93e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGFR2—cleft lip	6.88e-05	9.73e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGFR1—cleft lip	6.88e-05	9.72e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGF2—cleft lip	6.69e-05	9.46e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MYC—cleft lip	6.68e-05	9.45e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOS3—cleft lip	6.6e-05	9.33e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FGF2—cleft lip	6.55e-05	9.26e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGFR3—cleft lip	6.5e-05	9.19e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOS3—cleft lip	6.46e-05	9.13e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGFR1—cleft lip	6.41e-05	9.07e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGFR3—cleft lip	6.06e-05	8.57e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FGF2—cleft lip	5.7e-05	8.06e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOS3—cleft lip	5.62e-05	7.95e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FGF2—cleft lip	5.43e-05	7.67e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOS3—cleft lip	5.35e-05	7.57e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FGF2—cleft lip	5.02e-05	7.1e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOS3—cleft lip	4.95e-05	7e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FGF2—cleft lip	4.68e-05	6.62e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOS3—cleft lip	4.62e-05	6.53e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MYC—cleft lip	4.37e-05	6.18e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MYC—cleft lip	4.28e-05	6.06e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MYC—cleft lip	3.73e-05	5.27e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MYC—cleft lip	3.55e-05	5.02e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MYC—cleft lip	3.28e-05	4.64e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MYC—cleft lip	3.06e-05	4.33e-05	CbGpPWpGaD
